Diabetes has been recognized as a "global health emergency" with an estimated 9% of adults being affected. However, about half of these adults remain undiagnosed. Conventional screening tools like fasting plasma glucose (FPG), oral glucose tolerance testing (OGTT) and glycosylated haemoglobin (HbA1c) can be inconvenient and expensive in a community-based setting. The Indian Diabetes Risk Score (IDRS) is a simple, non-invasive tool which has been validated for use in the Indian population. Age, abdominal obesity, family history of diabetes and physical activity levels have been weighted for a maximum score of 100. Persons with IDRS of <30 are categorized as low risk, 30-50 as medium risk and those with > 60 as high risk for diabetes. A community based, cross-sectional, analytical study was planned to assess the performance of IDRS among adults in a semi-urban area in Kathmandu, Nepal. A total of 256 (170 female, 86 male) persons without diabetes from 260 households were screened during the study period. A majority (46.09%) were classified as high risk, 44.53% as moderate risk and 9.38% as low risk for developing diabetes. Among them, 162 (63.28%) volunteered for definitive testing. The prevalence of undiagnosed diabetes and prediabetes was 4.32% (95% CI: 1.75% to 8.70%) and 7.14% (95% CI: 3.89% to 12.58%) respectively. IDRS predicted the combined risk of diabetes and prediabetes with sensitivity of 84.21% and specificity of 55.24% in adults with score of 60 and above. The area under the ROC curve (AUC) of IDRS for identifying diabetes and prediabetes was 0.69 as compared to the gold standard (2hour Plasma Glucose) AUC of 0.98. IDRS may be a suitable screening tool for diabetes and prediabetes in the adult Nepalese study population.
Introduction
Diabetes has been recognized as "one of the largest global health emergencies of the 21st century". 1 Type 2 diabetes (T2D) accounts for up to 90% of diabetes worldwide. 2 Globally, 9% of adults are estimated to have diabetes, with 1 in 2 adults being undiagnosed. Up to 80% of individuals with undiagnosed diabetes are believed to live in low and middle income countries. 3 Diagnosed T2D is only the tip of the iceberg of an epidemic of glucose intolerance. Defects in the action or secretion of insulin are the two major abnormalities leading to development of glucose intolerance. The natural history of T2D includes a preceding period of impaired glucose tolerance (IGT) or impaired fasting glucose (IFG). 4 Prediabetes (IFG and IGT) refers to this stage between normal blood glucose levels and diabetes. They represent persons who are at risk of developing diabetes mellitus in the future. 5 Diabetes screening is a search for undiagnosed diabetes as well as to identify those who are at risk of developing diabetes. The choice of a screening method should be made on the basis of prevalence of undiagnosed diabetes in the community, the accuracy and cost of the test. 6 The fasting plasma glucose (FPG), oral glucose tolerance test (OGTT) and glycated haemoglobin are commonly used tests in high resource settings. 7 In the community setting, random capillary blood glucose (RCBG) and urine glucose testing may provide a good compromise between accuracy and cost effectiveness. 8 Diabetes risk scores are simple, fast, inexpensive, non-invasive and reliable screening tools. They utilize specific variables or risk factors to calculate an individuals' risk of developing diabetes. They do not quantify the risk of diabetes but help to identify individuals at high risk in a time gap between 5-10 years. 9 The Indian Diabetes Risk Score (IDRS) is comprised of four scored questions regarding age, abdominal obesity as measured by the waist circumference, family history of diabetes and physical activity levels. It is a simple, easy to administer screening tool to detect undiagnosed diabetes and to identify persons at risk of developing diabetes. 10 The IDRS validation was carried out among the Chennai Urban and Rural Epidemiological study (CURES) population. An IDRS value of ≥ 60 was recommended as the cut-off to classify persons as high risk. Persons with high risk classification can be recommended to undergo definitive testing. IDRS was proposed to make screening programmes in India more cost effective. 10 A systematic review of risk scores or prediction models has suggested that such tools often work well in the population that they have been validated in. The predictive values of risk scores can vary widely between populations. Hence, prior to utilization of a tool, the ease of implementation, cut off points and validation of the risk score in a proposed population needs to be considered. 9 A systematic review and meta-analysis on the prevalence of T2D in Nepal reported a minimum of 1.4% to a maximum of 19.0% with a pooled prevalence of 8.4%. The prevalence of type 2 diabetes in urban and rural populations was 8.1% (95% CI: 7.3-8.9%) and 1.0% (95% CI: 0.7-1.3%), respectively. 11
This study was planned to assess the prevalence of undiagnosed type 2 diabetes, identify those who are at high risk of developing T2D (prediabetes) in the community and assess the performance of the IDRS as a screening tool among an adult population in a semi-urban area in Kathmandu, Nepal.
Materials and Methods
A community-based cross-sectional, observational and analytical study was carried out in the Budhanilkantha Municipality from September 2017 to May 2018.
Assuming a baseline prevalence of diabetes in Nepal of 8.4% as an equivalent proportion of undiagnosed diabetes, a 5% margin of error and a non-response rate of 20%, the minimum sample size was calculated to be 142 adults who were not previously diagnosed with diabetes.
For assessing the performance of IDRS, all of the study participants who were not previously diagnosed with diabetes were invited for an oral glucose tolerance test (OGTT) (WHO 1998 criteria) for definitive testing.
Sampling technique: Using a simple random sampling technique, 260 households were selected for a family survey from an estimated 600 households in the study area. Data collection was carried out in a step wise manner which increased the initial response rate for screening for diabetes and helped to acquire the number needed to undertake definite testing. 12
Step 1: Adults over 20 years of age who were present in the household and not pregnant at the time of the survey were interviewed using a pretested structured questionnaire (modified STEPS survey) and IDRS screening tool after obtaining due written consent by trained UG medical students supervised by faculty from the department of Community Medicine. 13
Step 2: Physical measurement of height, weight, waist circumference and hip circumference was carried out at the household level as a part of the family study assessment.
Step 3: Estimation of the random capillary plasma glucose (RCBG) levels was offered to all the participants using a glucometer at the household level. Faculty and trained UG students carried out this testing during the study period.
Step 4: All of the study participants were invited to undergo an OGTT as recommended by the WHO guidelines using 75g of glucose. 5 Fasting plasma glucose (FPG) and 2-hour plasma glucose (2 hr PG) samples were collected through a screening camp organized over 7 days in the community. Faculty from the departments of Community Medicine and Biochemistry conducted the screening camp along with the co-operation of community leaders and representatives, screened households and UG medical students. The volunteers were advised to consume the last meal by 8pm so that they were fasting for a minimum of 10 hours at the time of the testing.
The camp began at 6:45 am in the morning at a predetermined venue in the community considering the convenience of the volunteers. Fasting blood samples were collected by 8 a.m. and all the 2-hour OGTT samples were collected by 10 a.m. The volunteers were advised to rest and refrain from strenuous activities during the testing period and to report any adverse effects following glucose administration.
Oral Glucose Tolerance Test
A fasting sample of venous blood was collected in a fluoride containing tube. The volunteers were given 75 grams of glucose dissolved in water (about 250-300 ml). The time of oral glucose administration was noted. Another venous blood sample was collected in a fluoride containing tube after 2 hours of glucose loading.
Collected venous blood samples were stored in a lab specimen transport bag and kept protected from direct sunlight. All specimens collected were delivered to the laboratory within 4 hours of collection for the separation of plasma from the cells. The samples were centrifuged at 3000 rpm for 15 minutes and were estimated for plasma glucose by autoanalyzer (Johnson & Johnson Vitros 250, USA) using glucose oxidase method in the laboratory of NMCTH.
Using the WHO 1999 consulting group criteria, diabetes was defined as FPG ≥126 mg/dl or 2hr PG ≥200 mg/dl. Prediabetes was defined as two categories, impaired fasting glucose (IFG) as FPG ≥110 and <126 mg/dl with 2hr PG <140 mg/ dl. Impaired glucose tolerance (IGT), the second category in prediabetes was defined as FPG <110 mg/ dl and 2hr PG ≥140 and <200 mg/dl. Prediabetes and diabetes were collectively labelled as 'Raised blood glucose'. Normoglycemia was defined as FPG <110 mg/dl and 2hr PG <140 mg/dl. 3, 5 Persons with previously diagnosed diabetes during the screening period were labelled as 'known diabetes'.
A total of 306 persons were screened during the study period. Fifty persons were found to be previously diagnosed cases of diabetes. The study participants without diabetes (n= 256) were invited to undergo an OGTT. One hundred and sixty-two participants (63.28%) responded to our invitation. One hundred and fifty-nine participants underwent the OGTT. Three participants were tested for plasma glucose levels after a meal (post prandial) as they either vomited or were unable to drink the glucose solution. 
Results
Fifty persons were found to be previously diagnosed cases of diabetes, the prevalence of known diabetes (50/ 306) was an estimated 16.34% (95% CI: 12.62% to 20.90%). (Table-1 The prevalence of undiagnosed diabetes was 4.32% (95% CI 1.75% to 8.70%) and that of prediabetes was 7.14% (95% CI 3.89% to 12.58%). The overall 
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Silvanus et al prevalence of persons with 'raised blood glucose' was 11.73% (95% CI 5.64% to 21.28%). Among the persons with prediabetes (n=12), three had both IFG and IGT and nine had IGT (Table-7 ).
The tabulated sensitivity (true positive rate) of the IDRS cut-off score ≥60 (high risk classification) was found to be 84.21% with a specificity (true negative rate) of 55.24%. The false positive rate and false negative rate was 44.76% and 15.79% respectively. The positive predictive value was 20.0% and negative predictive value was 96.34% (Table-8 ).
On ROC curve analysis of IDRS cut-offs for the identification of persons with 'raised blood glucose', the 50 and above score had a 100% sensitivity with a low specificity of 27.27% and an accuracy of 35.80%. Increasing the cut-off to 70 and above, raised the specificity to 86.01% with a decrease in the sensitivity to 31.58%. The IDRS recommended cut-off of 60 and above was found a sensitivity and specificity of 84.21% and 55.24% with an accuracy of 58.64%. The positive likelihood ratio was 1.88 and the negative likelihood ratio was 0.28 at this cut-off (Table-9 ).
The IDRS ROC AUC for a score of 60 and above was 0.69 (95% CI 0.62 to 0.77) as compared to 0.87 for FPG and 0.98 for the gold standard 2 hr PG for the identification of persons with raised blood glucose ( Fig. 1) .
Discussion
In the present study, IDRS identified just under half of the screened population (46.05%) as high risk for developing diabetes. In comparison, in a study carried out in a semi-urban area near Chennai, India (n= 304) about 37% were found to be at high risk. The lower age (41.5 years vs 49.15 years) may have accounted for the lower proportion. 14 The association between diabetes and hypertension has been well documented in literature. 15, 16 The positive association of IDRS value 60 and above with hypertensive status as seen in the present study may add to the utility of screening with IDRS.
The definitive testing yielded a prevalence of undiagnosed diabetes which ranged between 1.75% to 8.70%. The prevalence of prediabetes was higher at about 3.89% to 12.58%. In comparison with the prevalence of known diabetes (50/306) during the screening period, about one in eight persons with diabetes was found to be undiagnosed. Prevalence of undiagnosed diabetes was lower than the global estimates of 1 in 2 persons. The higher yield of prediabetes as compared to diabetes also suggests an increased awareness about diabetes among the screened population. As the yield of raised blood glucose in the present study was small, further linear or logistic regression analysis was not performed. A similar study was carried out in Mangalore, India among 551 adults. The response rate for OGTT was higher than that of the present study (68.9% vs 63.28%). The study reported a sensitivity of 62.2% and a specificity of 73.7% for the IDRS cut-off ≥ 60. In comparison, the sensitivity in our study was higher at 84.21% with a lower specificity of 55.24%. 17 It would be appropriate to argue here that a screening test would need to be more sensitive than specific as found in the present study. 6 In another IDRS validation study among adults in an urban slum in India (n=155), Dudeja et al reported an IDRS sensitivity and specificity of 95.12% and 28.95% respectively. This study however confirmed diabetes using only the fasting blood sugar testing. 18 The World Health Organization (WHO) and the International Diabetes Federation (IDF) have recommended that OGTT be used for the diagnosis of diabetes. The American Diabetes Association (ADA) however differed and suggested the use of FPG in the diagnosis of diabetes. ADA has also lowered the cut-off of IFG to 100 mg/dl from 110 mg/dl. 19, 20 In the present study, a majority of the 'raised blood glucose' yield was due to the post glucose 2-hr PG testing.
Another community based validation study carried out in an urban North Indian population (n= 615) reported that an IDRS score of 60 and above had a lower sensitivity of 45.5% and a higher specificity of 88.0%. 21 Likelihood ratios were reported to assess the potential utility of IDRS. The positive likelihood ratio (LR+) was the ratio of true positives to false positives. LR + of about 2 was interpreted as an increase in the probability of diabetes or prediabetes by 15% for a person with an IDRS score of 60 or more. On the other hand, negative LR (LR-) was the ratio of false negatives to true negatives. LR-of 0.32 was interpreted as a 30% decrease in the probability of diabetes or prediabetes for an individual with an IDRS score less than 60. 22 Non-invasive risk stratification tools have been recommended as a cost-effective method of screening for diabetes and prediabetes. The present study findings suggest that the IDRS may be an appropriate tool to screen for diabetes and prediabetes among the adult population in Kathmandu, Nepal. With a negative predictive value of about 97%, the IDRS may also be useful in a clinical setting to decide which individual may or may not need definitive testing. This may help to reduce the out of pocket (OOP) expenditure for the individual in a low-and middle-income nation such as Nepal. 23 However, IDRS may have overestimated the actual risk of diabetes as seen by the 44.76% false positive rate. Another concern raised was, 'how likely were the persons with prediabetes to have developed diabetes'? A meta-analysis of observational studies among persons with prediabetes reported that the progression to a state of diabetes was estimated to be 47 per 1000 person years for persons with IFG, 56 per 1000 person years for IGT and 76 per 1000 person years for both IFG and IGT. 24, 25 This suggested that persons with an impairment of both fasting as well as post-prandial glucose levels were more likely to develop diabetes in the near future. IDF guidelines suggest that persons who screen negative should be retested after 3-5 years. 3 A follow up testing of the cohort of 'false positive' persons over the next 5-10 years would probably best answer this concern.
Strengths of the study: The community-based study design to screen for undiagnosed diabetes, the step wise approach including the non-invasive tool and estimation of RCBG and the use of both FPG and the 2hr PG following a 75g OGTT to identify diabetes and prediabetes are the main strengths of this study.
Limitations of the study:
A community-based screening program can attract persons who have the health condition, those with a propensity to seek health care or who are more interested in their health which can introduce a selection bias. We tried to minimize this bias by screening about 43.33% of the households in the community to secure a representative sample (n=304). Persons with diabetes were eager participants in the screening program (n=50); while offering them testing facilities, they were excluded from the data analysis for the IDRS performance. Response rate for the definitive testing was 63.28% among those without diabetes (n=256) and yielded a number which was well over the required sample size. However, a greater response may have improved the yield of undiagnosed diabetes in the screened population.
In conclusion, the IDRS value of 60 and above predicted the overall risk of diabetes and prediabetes with a sensitivity of 84.21% and specificity of 55.24% among the screened population. The persons with screen-detected diabetes were offered treatment and care at our tertiary health care facility. Screening with IDRS also provided an opportunity for primary prevention among persons with prediabetes or a high-risk classification focusing on diet, physical activity and weight management. This may help to prevent or delay the progression to diabetes among these persons. IDRS may be a suitable screening tool for diabetes and prediabetes in the adult Nepalese study population.
